Position in IMVT
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,161,687
+$752,167 QoQ
Shares Held
56,104
-1.1% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#85
of 226 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Derivatives in IMVT
reported options exposure · as of Dec 31, 2024CallValue
$182
CallShares
1,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026HighTower Advisors, LLC holds $312,855,129 across 115 Biotechnology names. IMVT ranks #17 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
870,551 | $82,484,707 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
64,650 | $40,311,861 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
105,045 | $31,621,696 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,020 | $24,349,704 | |
| 5 | RPRX |
Royalty Pharma plc
|
285,630 | $16,015,274 | |
| 6 | EXEL |
Exelixis, Inc.
|
291,162 | $15,842,124 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
56,313 | $13,783,733 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
140,394 | $11,443,514 |
All Filings in IMVT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,161,687 | 56,104 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,409,520 | 56,744 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $849,231 | 33,408 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $538,536 | 33,408 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $534,272 | 33,392 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $568,635 | 33,273 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $182 | 1,000 | Call | Sole | 2025-02-07 | |
| 2024-12-31 | $818,276 | 33,035 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $947,216 | 33,224 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $2,168 | 1,000 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $685,476 | 25,965 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $883,484 | 27,344 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,151,117 | 27,323 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $933,759 | 24,323 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $459,965 | 24,247 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $376,070 | 24,247 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $430,384 | 24,247 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $135,298 | 24,247 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $94,563 | 24,247 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $133,600 | 24,247 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $206,584 | 24,247 | Shares | Sole | 2022-02-10 | |
| 2020-12-31 | $212,474 | 4,600 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||